Skip to main content
Log in

The effect of timing of a single injection on the toxicity of methotrexate in the rat

  • Original Articles
  • Timing and Methotrexate Toxicity
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The possibility of a circadian rhythm in the toxicity of methotrexate was investigated in rats after a single intravenous bolus. Indices of haematological, renal and hepatic toxicity were studied, as were the pharmacokinetics of the drug. All the parameters showed a circadian variation, with maximum toxicity occurring after dosage at 06.00 h and minimum toxicity after dosage at midnight. Administration at the other two time points, 12.00 h and 18.00 h, gave intermediate results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aherne GW, Piall EM, Marks V (1977) Development and application of a radioimmunoassay for methotrexate. Br J Cancer 36:608

    Google Scholar 

  2. Baker H, Dahl MGC (1969) Methotrexate and the liver. Br J Dermatol 81:465

    Google Scholar 

  3. Brodie BB (1965) Symposium on Drug Interaction. Proc R Soc Med 58:946

    Google Scholar 

  4. Burns ER, Scheving LE (1980) Circadian optimisation of the treatment of L1210 leukaemia with 1-β-d-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone. Chronobiologia 7:41

    Google Scholar 

  5. Cambar J, Lemoigne F, Toussaint C, Dost C (1978) Étude des variations nycthémérales du taux sérique et urinaire de l'urée, de la créatinine et des proteines totales chez le rat. C R Soc Biol 172:894

    Google Scholar 

  6. Cambar J, Lemoigne F, Toussaint C (1979) Étude des variations nycthémérales de la filtration glomérulaire chez le rat. Experientia 35:1607

    Google Scholar 

  7. Condit PT, Chanes RE, Joel W (1969) Renal toxicity of methotrexate. Cancer 2:126

    Google Scholar 

  8. Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA (1948) Temporary remissions in acute leukaemia in children produced by folic acid antagonist, 4-aminopteryl-glutamic acid. N Engl J Med 238:787

    Google Scholar 

  9. Fawcett JK, Scottl JE (1960) Measurement of blood urea nitrogen levels. J Clin Pathol 13:156

    Google Scholar 

  10. Focan C (1979) Sequential chemotherapy and circadian rhythm in human solid tumours. Cancer Chemother Pharmacol 3:197

    Google Scholar 

  11. Goldie JH, Price LA, Harrap KR (1972) Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. Eur J Cancer 8:409

    Google Scholar 

  12. Halberg F, Haus E, Cardoso SS, Scheving LE, Kuhl JFW, Shiotsuka R, Rosene G, Pauly JE, Runge W, Spalding JF, Lee JK, Good RA (1973) Toward a chronotherapy of neoplasia: tolerance of treatment depends on host rhythms. Experientia 29:909

    Google Scholar 

  13. Hansen HH, Selawry OS, Holland JF, McCall CB (1971) The variability of individual tolerance to methotrexate in cancer patients. Br J Cancer 25:298

    Google Scholar 

  14. Haus E, Halberg F, Scheving LE, Pauly JE, Cardoso S, Kuhl JFW, Southern RB, Shiotsuka RN, Hwang DS (1972) Increased tolerance of leukaemic mice to arabinosyl cytosine with schedule adjusted to circadian rhythm. Science 177:80

    Google Scholar 

  15. Henderson ES, Adamson RH, Denham C, Oliverio VT (1965) The metabolic fate of tritiated methotrexate. 1. Absorption, excretion and distribution in mice, rats, dogs and monkeys. Cancer Res 25:1008

    Google Scholar 

  16. Hrushesky W, Levi F, Kennedy BJ, Theologides A (1981) Results of circadian time qualified chemotherapy in patients with advanced ovarian cancer. ASCO Abstracts C-546:472

    Google Scholar 

  17. Kuhl JFW, Grage TB, Halberg F, Rosene G, Scheving LE, Haus E (1973) Ellen effect: tolerance of adriamycin by Bragg albino mice and Fischer rats depends on circadian timing of injection. Int J Chronobiol 1:335

    Google Scholar 

  18. Levitt M, Mosher MB, DeConti RC, Farber LR, Skeel RT, Marsh JC, Mitchell JLS, Papac RJ, Thomas ED, Bertino JR (1973) Improved therapeutic index of methotrexate with “leucovorin rescue”. Cancer Res 33:1729

    Google Scholar 

  19. Owasoyo JO, Walker CA (1981) Circadian variations of diazepam acute toxicity. Experientia 32:72

    Google Scholar 

  20. Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56

    Google Scholar 

  21. Rosene G, Lee JK, Kuhl JFW, Halberg F, Grage TB (1973) Adriamycin in advanced L1210 leukaemia. Int J Chronobiol 1:356

    Google Scholar 

  22. Scheving LE, Burns ER, Pauly JE, Halberg F, Haus E (1977) Survival and cure of leukaemic mice after circadian optimisation of treatment with cyclophosphamide and 1-β-d-arabinofuranosyl cytosine. Cancer Res 37:3648

    Google Scholar 

  23. Seelig HP, Wust H (1969) A simple colorimetric method for serum creatinine determination. Aerztl Lab 15:34

    Google Scholar 

  24. Sheving L (1968) Daytime variations in amphetamine disposal. Nature 219:621

    Google Scholar 

  25. Stoller RG, Kaplan HG, Cummings FJ, Calabresi P (1979) A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue. Cancer Res 39:908

    Google Scholar 

  26. Vesell ES (1968) Factors altering the responsiveness of mice to hexobarbital. Pharmacology 1:81

    Google Scholar 

  27. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton

    Google Scholar 

  28. Zaharko DS, Oliverio VT (1970) Reinvestigation of methotrexate metabolism in rodents. Biochem Pharmacol 19:2923

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

English, J., Wynne Aherne, G. & Marks, V. The effect of timing of a single injection on the toxicity of methotrexate in the rat. Cancer Chemother. Pharmacol. 9, 114–117 (1982). https://doi.org/10.1007/BF00265390

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265390

Keywords

Navigation